In the News | Charles River

   
 
 
   
   

Insourcing is the New Outsourcing in Biopharma
Life Sciences Leader - June 2009

As patent expirations loom and economic and regulatory pressures increase, the pharmaceutical and biotech industries are looking for new ways to bring compounds to market quickly, safely, and cost-effectively. The amount of time and investment required to conduct, analyze, and document clinical trials has grown enormously in the past 25 years, and many pharmaceutical companies have chosen to focus on pure research, while contracting out development and regulatory work to contract research organizations (CROs).

Contract research already accounts for more than 17% of total drug development spending, according to the Tufts Center for the Study of Drug Development, and this number is likely to increase. With dependence on contract research increasing, CROs are finding new, creative ways to embed their expertise in R&D pipelines. One of these new outsourcing ideas is sometimes called “insourcing”...Read the full article.

   
Discover the full range of Charles River Products and Services

For more information please call:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
Aug 26 - Charles River to Participate in th...
Apr 26 - Charles River and WuXi to Combine
Sep 20-Sep 23 - Boston, MA - Safety Pharmacology Society Annual Meeting
Sep 15-Sep 17 - Stratford-Upon-Avon, England - Charles River LAL Seminar Series
Sep 13-Sep 15 - San Diego, CA - 16th Annual Symposium on Biotechnology-Derived Therapeu...
view all
Manager Corporate Consolidation Wilmingto...
IT Specialist II - Web Development  
Senior Tax Analyst Wilmington, MA
Director, Clinical Specialist Sales 

Charles River Laboratories, Inc.